Extendicare Inc. (TSE:EXE - Get Free Report) announced a monthly dividend on Thursday, April 30th, TickerTech Dividends reports. Investors of record on Friday, May 15th will be paid a dividend of 0.0441 per share on Friday, May 15th. This represents a c) dividend on an annualized basis and a yield of 1.8%. The ex-dividend date is Thursday, April 30th.
Extendicare Price Performance
Shares of TSE EXE opened at C$29.90 on Tuesday. The business's 50 day moving average price is C$26.98 and its 200 day moving average price is C$22.76. The firm has a market cap of C$2.82 billion, a P/E ratio of 26.86 and a beta of 1.18. Extendicare has a 52 week low of C$12.12 and a 52 week high of C$29.99. The company has a quick ratio of 0.98, a current ratio of 1.37 and a debt-to-equity ratio of 91.85.
Extendicare (TSE:EXE - Get Free Report) last issued its earnings results on Thursday, February 26th. The company reported C$0.29 EPS for the quarter. The firm had revenue of C$462.03 million for the quarter. Extendicare had a return on equity of 47.65% and a net margin of 5.82%. On average, sell-side analysts expect that Extendicare will post 0.6134729 earnings per share for the current year.
About Extendicare
(
Get Free Report)
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Extendicare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Extendicare wasn't on the list.
While Extendicare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
